Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

Himalaya's Liv.52/LiverCare Approved as a Herbal Drug in Switzerland
2002-04-04 - Himalaya USA




HOUSTON--(BW HealthWire)--April 4, 2002--In what is believed to be the first multi-herb remedy granted regulatory approval as a drug, Liv.52, the well-known hepatoprotective product of The Himalaya Drug Company, has recently been registered a safe and effective drug by the "Intercantonal Office for the Control of Medicines," Switzerland's equivalent of the United States' FDA.

"This outstanding feat comes at a time when lack of governmental oversight around the world has cast a shadow over the quality of many herbal products on the market," says Dr. Philip Duterme, president and CEO of Himalaya USA, the exclusive North American distributor of Liv.52 (LiverCare) and other products of The Himalaya Drug Company. "It speaks volumes about the level of quality herbal products can reach today. The phrase 'pharmaceutical grade herbal remedies' is not an oxymoron any longer when considering what pharmaceutical-based natural health companies are capable of producing."

First introduced in 1955 by The Himalaya Drug Company, Liv.52 (LiverCare) is a proprietary blend of several botanicals proven to protect the liver against harmful toxins found in drugs, alcohol, food and water. It acts by regulating enzymes and optimizing assimilation in the body. It also protects the liver against possible damage caused by hepatotoxic prescription medications.

More than 300 clinical studies, many double-blind, placebo-controlled, have been performed on Liv.52 (LiverCare) since its introduction more than 47 years ago. Since then, it has become one of the most widely sold medications in the world with more than two billion tablets produced annually.

The approval of Liv.52 (LiverCare) by the Swiss Health authorities also underscores the gigantic achievement by The Himalaya Drug Company of a total quality management program that oversees the entire production process "from seed to shelf" and controls quality using the most sophisticated chromatographic "fingerprinting" techniques available.

"Himalaya USA is proud to offer such high-end herbal remedies in the United States. We have always known that we are second to none in terms of scientific evidence and our ability to maintain consistent quality. What better certification can one get than such an endorsement by a prestigious national health authority?" says Duterme.

The Himalaya Drug Company has been manufacturing pharmaceutical grade herbal products since 1930. Himalaya products combine the rich therapeutic value of an old system of natural medicine with all the processes of modern pharmaceutical technology. For more information, please visit www.himalayausa.com

--30--AA/ho*

 

Advertisement



Sponsored Links: Featured Links:
 

NPIcenter Address and Phone Number
Contact Us | Privacy Policy | Terms of Use | Advertise
New Hope Natural Media

 

SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon